Gene · 6278
Papers2,053
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,053
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Features of Shared Genes among Transcriptomes Probed in Atopic Dermatitis, Psoriasis, and Inflammatory Acne: S100A9 Selection as the Target Gene. | Protein Pept Lett | 2024 | 38766834 | PubTator, text mining | PubMed |
| Upregulation of psoriasin/S100A7 correlates with clinical severity in patients with oral lichen planus. | Clin Oral Investig | 2024 | 38750317 | PubTator, text mining | PubMed |
| The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma. | Cancer Lett | 2024 | 38734159 | PubTator, text mining | PubMed |
| Single-cell and bulk RNAseq unveils the immune infiltration landscape and targeted therapeutic biomarkers of psoriasis. | Front Genet | 2024 | 38699235 | PubTator, text mining | PubMed |
| Ursolic Acid Formulations Effectively Induce Apoptosis and Limit Inflammation in the Psoriasis Models In Vitro. | Biomedicines | 2024 | 38672088 | PubTator, text mining | PubMed |
| Drug repositioning for immunotherapy in breast cancer using single-cell analysis. | NPJ Syst Biol Appl | 2024 | 38589404 | PubTator, text mining | PubMed |
| Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years. | Allergy | 2024 | 38563683 | PubTator, text mining | PubMed |
| Atlas of Tumor and Tumor Microenvironment Cells of Lymphovascular Space Invasion (LVSI) in High-Grade Serous Endometrial Adenocarcinoma: A Case Study. | Int J Mol Sci | 2024 | 38542414 | PubTator, text mining | PubMed |
| Dynamics and Epigenetics of the Epidermal Differentiation Complex. | Epigenomes | 2024 | 38534793 | PubTator, text mining | PubMed |
| Correlation between S100A7 and immune characteristics, methylation, tumor stemness and tumor heterogeneity in pan-cancer and its role in chemotherapy resistance in breast cancer. | Aging (Albany NY) | 2024 | 38499391 | PubTator, text mining | PubMed |
| Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer. | Int J Mol Sci | 2024 | 38473906 | PubTator, text mining | PubMed |
| Machine learning predictor PSPire screens for phase-separating proteins lacking intrinsically disordered regions. | Nat Commun | 2024 | 38459060 | PubTator, text mining | PubMed |
| Identification of a shared gene signature and biological mechanism between diabetic foot ulcers and cutaneous lupus erythemnatosus by transcriptomic analysis. | Front Physiol | 2024 | 38434138 | PubTator, text mining | PubMed |
| Upper Airway Epithelial Tissue Transcriptome Analysis Reveals Immune Signatures Associated with COVID-19 Severity in Ghanaians. | J Immunol Res | 2024 | 38375062 | PubTator, text mining | PubMed |
| Effects of topical application of resveratrol on tight junction barrier and antimicrobial compound production in lactating goat mammary glands. | Vet Res | 2024 | 38365712 | PubTator, text mining | PubMed |
| Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade. | Nat Commun | 2024 | 38291032 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals keratinocyte subpopulations contributing to psoriasis in corneum and granular layer. | Skin Res Technol | 2024 | 38279596 | PubTator, text mining | PubMed |
| Exploring the comorbidity mechanisms between psoriasis and obesity based on bioinformatics. | Skin Res Technol | 2024 | 38279589 | PubTator, text mining | PubMed |
| The Influence of Platelet-Rich Fibrin on the Healing of Bone Defects after Harvesting Bone-Patellar Tendon-Bone Grafts. | Medicina (Kaunas) | 2024 | 38256414 | PubTator, text mining | PubMed |
| Damage-Associated Molecular Patterns, a Class of Potential Psoriasis Drug Targets. | Int J Mol Sci | 2024 | 38255845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6278/papers?page=5